Adults with hidradenitis suppurativa treated with adalimumab have a greater risk for serious infections than those with ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...

Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

Given GLP-1 receptor agonists' established effects on weight, Poizeau and colleagues investigated whether the blockbuster ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

Hidradenitis suppurativa (HS) is a chronic condition of the sebaceous glands that commonly occurs in those prone to acne. Although there is no cure, the condition can be managed through medications.

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

The use of combined estrogen-progesterone oral contraceptives (COC) as monotherapy or combination treatment may improve outcomes in patients with hidradenitis suppurativa (HS), according to the ...